Portrait of Julien Lambert

Clinical Trial Manager · Clinical Scientist · PhD

Julien Lambert

My journey in science began with a desire to understand the mechanics of living organisms, leading me to a PhD focused on varicella-zoster virus protein interactions. Wanting to apply this expertise directly to human therapeutics, I have built a career in clinical trials, accumulating over four years of experience within global vaccine and biotech programs. Across my roles at GSK Vaccines and argenx, I have channeled this analytical rigor into designing data cleaning strategies, managing medical and safety oversight, and leading cross-functional teams. I am dedicated to advancing innovative global health solutions through efficient, high-quality clinical development.

Medical Monitoring ICH-GCP · GVP Protocol Development RBQM · Risk Management

Career timeline

Scroll the timeline — the bar below tracks the active role on a real time scale.

    Education & Certifications

    Education

    • 2022

      PhD in Sciences (Biochemistry)

      ULiège, Belgium

    • 2016

      MSc Biochemistry, Molecular & Cellular Biology

      ULiège, Belgium

    • 2014

      Bachelor in Biology

      ULiège, Belgium

    Certifications

    • 2024

      Certificate course in Vaccinology

      Pasteur Institute

    • 2024

      Certificate in Pharmacovigilance

      Udemy

    • 2021

      CLINET training

      Aptaskil

    • 2021

      GxP's and Medical Devices

      Le Forem

    Skills

    From wet-lab biochemistry to clinical data platforms — a stack built for evidence generation.

    Clinical Trial Leadership

    • Study setup & operational design
    • Cross-functional team coordination
    • Risk identification, mitigation & escalation
    • Medical & safety oversight, DMC support
    • Vendor / CRO interface

    Clinical & Regulatory

    • ICH-GCP, GVP, GxP
    • Protocol & medical review charter authoring
    • Clinical trial conduct & monitoring oversight
    • Study documentation & SOP compliance
    • Audit & inspection readiness

    Platforms & Data

    • eCRF: Veeva CDMS, Inform
    • Data review: elluminate, Spotfire, Cluepoints MSR
    • RBQM / iDRP roll-outs
    • JIRA governance, MS Office suite

    Languages

    • French Native
    • English C1
    • Dutch A1
    • German A1
    • Italian 446d A1

    Beyond the CV

    A snapshot of what I'm currently into, and where I've worked along the way.

    Currently

    • Reading

      Ocean: Earth’s Last Wilderness by David Attenborough & Colin Butfield

    • Learning

      Italian on Duolingo — 446-day streak.

    • Running challenge · 2026

      420 km of 1,250 km goal

      33.60% · ~830 km to go

    • Civic role

      Member of the municipal advisory commission for land-use planning and mobility.

    Where the work happened

    From the Ardennes to Brussels — places that shaped the path.

    Zwijnaarde Evere Wavre Liège Huy Libramont
    • Born here

      Libramont, BE

    • Live here

      Huy, BE

    • Currently work here

      argenx · Zwijnaarde, BE

      Enovalife · Evere, BE

    • Worked here

      GSK Vaccines · Wavre, BE

      ULiège · Liège, BE

    Publications

    Peer-reviewed research on Varicella-Zoster virus biology and viral envelopment.

    1. Journal of Virology · 2018 20 citations Open access

      Lebrun M., Lambert J., Riva L., Thelen N., Rambout X., Blondeau C., Thiry M., Snoeck R., Twizere J.-C., Dequiedt F., Andrei G., Sadzot-Delvaux C. (2018). Varicella-Zoster virus ORF9p binding to cellular adaptor protein complex 1 is important for viral infectivity. Journal of Virology, 92(15).

    2. PhD Thesis · ULiège · 2022

      Lambert J. (2022). Varicella-Zoster virus ORF9p: role in viral envelopment and cell-cell fusion. Doctoral thesis, University of Liège.

    3. Manuscript · in preparation

      Lambert J. et al. (2026). ORF9p, a major and essential tegument protein, is involved in cell-cell fusion induced by Varicella-Zoster virus.

    4. Conference talk · Belvir 2019

      Lambert J. (2019). Varicella-Zoster virus ORF9p: hijacker of the autophagy pathway? Belgian Society for Virology, Brussels.

    5. Poster · Int'l Herpesvirus Workshop 2017

      Lambert J. et al. (2017). Study of the role of the complex formed by VZV ORF9p and adaptin protein-1 in the secondary egress. International Herpesvirus Workshop, Ghent.

    How this site was built

    This CV is a static single-page website — no framework, no tracking, no cookies. It loads fast and works offline once cached.

    Tech stack
    Hand-written HTML, modern CSS (custom properties, color-mix, container queries) and a small vanilla-JS module. SVG for the timeline arc, logos and motif.
    Typography
    Fraunces (display serif), Inter (UI sans), JetBrains Mono (metadata).
    Design choices
    Light/dark themes, animated language progress bars, scroll-driven career timeline with a revolving arc segment over a static task panel, and a stylised IgG / FcRn motif in the hero — a nod to the immunology background.
    Built with
    Drafted and iterated with Perplexity Computer as a pair-programming assistant — every line was reviewed and curated by Julien.
    Hosting
    Static hosting on Cloudflare Pages / Netlify, served behind a custom domain.

    Source files available on request — happy to walk through the implementation if it's relevant to the role.